Approvals/TGA/ABACAVIR/LAMIVUDINE VIATRIS abacavir (as sulfate)/lamivudine 600 mg/300 mg film-coated tablet blister pack

Approved

STANDARD

ABACAVIR/LAMIVUDINE VIATRIS abacavir (as sulfate)/lamivudine 600 mg/300 mg film-coated tablet blister pack

Alphapharm Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 43224b1681853731
Product Name: ABACAVIR/LAMIVUDINE VIATRIS abacavir (as sulfate)/lamivudine 600 mg/300 mg film-coated tablet blister pack
Artg Id: 266516
Artg Name: ABACAVIR/LAMIVUDINE VIATRIS abacavir (as sulfate)/lamivudine 600 mg/300 mg film-coated tablet blister pack
Sponsor: Alphapharm Pty Ltd
Company Detail Path: /organization/alphapharm-pty-ltd
Artg Date: 2017-11-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c28a7c10a5537097eca94fda1b5f4656.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/b98aafb56879fe4f1fdf766071d3c43c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

43224b1681853731

Type

Standard